RET oncogene mutations in 75 cases of familial medullary thyroid carcinoma in Japan

被引:13
作者
Kameyama, K
Okinaga, H
Takami, H
机构
[1] Keio Univ, Sch Med, Div Diagnost Pathol, Shinjuku Ku, Tokyo 1608582, Japan
[2] Univ Tokyo, Fac Med, Dept Nephrol & Endocrinol, Bunkyo Ku, Tokyo 113, Japan
[3] Teikyo Univ, Sch Med, Dept Surg, Itabashi Ku, Tokyo, Japan
关键词
medullary thyroid carcinoma; RET protooncogene; familial cancer;
D O I
10.1016/j.biopha.2004.05.001
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The familial form of medullary thyroid carcinoma (MTC) is caused by mutations of the RET protooncogene. We registered 60 multiple endocrine neoplasia (MEN) 2A patients, 12 familial non-MEN medullary carcinoma (FMTQ patients, and three MEN2B patients with a confirmed RET germline mutation. All 60 MEN2A patients had RET mutations in a cysteine-rich domain. Seven of the FMTC patients had a mutation in cysteine-rich domain, and the other five had a mutation in codon 768, which encodes a tyrosine-kinase domain. Two of the MEN2B patients had a mutation in codon 918, and one patient had a double mutation, one in codon 804 and the other in codon 806, both of which are all encoded tyrosine-kinase domain. The genotype-phenotype correlations of our data will allow individualized recommendations for the optimal timing of prophylactic surgery. (C) 2004 Elsevier SAS. All rights reserved.
引用
收藏
页码:345 / 347
页数:3
相关论文
共 16 条
  • [1] BOLINO A, 1995, ONCOGENE, V10, P2415
  • [2] MUTATIONS IN THE RET PROTOONCOGENE ARE ASSOCIATED WITH MEN 2A AND FMTC
    DONISKELLER, H
    DOU, SS
    CHI, D
    CARLSON, KM
    TOSHIMA, K
    LAIRMORE, TC
    HOWE, JR
    MOLEY, JF
    GOODFELLOW, P
    WELLS, SA
    [J]. HUMAN MOLECULAR GENETICS, 1993, 2 (07) : 851 - 856
  • [3] ENG C, 1995, ONCOGENE, V10, P509
  • [4] The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2 - International RET mutation consortium analysis
    Eng, C
    Clayton, D
    Schuffenecker, I
    Lenoir, G
    Cote, G
    Gagel, RF
    vanAmstel, HKP
    Lips, CJM
    Nishisho, I
    Takai, SI
    Marsh, DJ
    Robinson, BG
    FrankRaue, K
    Raue, F
    Xue, FY
    Noll, WW
    Romei, C
    Pacini, F
    Fink, M
    Niederle, B
    Zedenius, J
    Nordenskjold, M
    Komminoth, P
    Hendy, GN
    Gharib, H
    Thibodeau, SN
    Lacroix, A
    Frilling, A
    Ponder, BAJ
    Mulligan, LM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (19): : 1575 - 1579
  • [5] Fink M, 1996, INT J CANCER, V69, P312, DOI 10.1002/(SICI)1097-0215(19960822)69:4<312::AID-IJC13>3.3.CO
  • [6] 2-G
  • [7] Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation
    Gimm, O
    Marsh, DJ
    Andrew, SD
    Frilling, A
    Dahia, PLM
    Mulligan, LM
    Zajac, JD
    Robinson, BG
    Eng, C
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (11) : 3902 - 3904
  • [8] A MUTATION IN THE RET PROTOONCOGENE ASSOCIATED WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE-2B AND SPORADIC MEDULLARY-THYROID CARCINOMA
    HOFSTRA, RMW
    LANDSVATER, RM
    CECCHERINI, I
    STULP, RP
    STELWAGEN, T
    LUO, Y
    PASINI, B
    HOPPENER, JWM
    VANAMSTEL, HKP
    ROMEO, G
    LIPS, CJM
    BUYS, CHCM
    [J]. NATURE, 1994, 367 (6461) : 375 - 376
  • [9] A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma
    Hofstra, RMW
    Fattoruso, O
    Quadro, L
    Wu, Y
    Libroia, A
    Verga, U
    Colantuoni, V
    Buys, CHCM
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (12) : 4176 - 4178
  • [10] Genotype-phenotype correlations in hereditary medullary thyroid carcinoma:: Oncological features and biochemical properties
    Machens, A
    Gimm, O
    Hinze, R
    Höppner, W
    Boehm, BO
    Dralle, H
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03) : 1104 - 1109